Macular degeneration

EQS-News: FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region

Retrieved on: 
Wednesday, March 13, 2024

In addition, further market launches are planned in Algeria and other Gulf Cooperation Council (GCC) markets over the course of 2024.

Key Points: 
  • In addition, further market launches are planned in Algeria and other Gulf Cooperation Council (GCC) markets over the course of 2024.
  • This strategic collaboration aims to improve access to ophthalmic treatments in the MENA region.
  • Biosimilar and specialty medicines are integral to MS Pharma product portfolio and play a crucial role in advancing our growth objectives in the MENA region.
  • This approval supports the company's commitment to the Saudi market and its broader strategic initiatives within the kingdom."

A.I. Supercomputer Market Projected To Reach $3.3 Billion By 2028 with Significant Growth Expected

Retrieved on: 
Monday, March 4, 2024

A report from MarketsAndMarkets said that the AI supercomputer market is projected to grow from USD $1.2 billion in 2023 and is expected to reach USD $3.3 billion by 2028, growing at a CAGR of 22.0% from 2023 to 2028.

Key Points: 
  • A report from MarketsAndMarkets said that the AI supercomputer market is projected to grow from USD $1.2 billion in 2023 and is expected to reach USD $3.3 billion by 2028, growing at a CAGR of 22.0% from 2023 to 2028.
  • The report said: “The Government segment in the AI supercomputer market for application is expected to hold the largest market size during the forecast period in the AI supercomputer market.
  • Moreover, AI supercomputers are also being used to coordinate disaster relief efforts and provide assistance to victims of disasters.
  • AI supercomputers process vast datasets in real time, providing valuable insights into customer behavior, market trends, and operational efficiency.

A.I. Processors for Cloud & Data Centers Forecasted to Increase to $38 Billion Dollars By 2026

Retrieved on: 
Wednesday, February 21, 2024

As AI becomes increasingly integrated into various industries, data centers must be equipped with the latest hardware to meet computational requirements.

Key Points: 
  • As AI becomes increasingly integrated into various industries, data centers must be equipped with the latest hardware to meet computational requirements.
  • Data centers underpin the remote management and orchestration of resources, enhancing operational efficiency.
  • Precedence Research continued: “Edge computing, which involves processing data closer to its source, demands decentralized data center infrastructure.
  • Data centers at the edge need to be compact, energy-efficient, and highly responsive to deliver real-time processing capabilities.

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

Retrieved on: 
Thursday, March 7, 2024

Ophthalmic Drug Packaging Market Overview:

Key Points: 
  • Ophthalmic Drug Packaging Market Overview:
    The global ophthalmic drug packaging market is expected to grow steadily, reaching an estimated value of US$527.8 million by 2034, according to Future Market Insights' recent study.
  • One of the challenges in the global ophthalmic drug packaging market is assuring compatibility between novel packaging materials and sensitive ophthalmic medicines.
  • The global ophthalmic drug packaging market size reached US$ 222.3 million in 2019.
  • Future Market Insights offers an unbiased analysis of the ophthalmic drug packaging market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

Retrieved on: 
Thursday, March 7, 2024

Ophthalmic Drug Packaging Market Overview:

Key Points: 
  • Ophthalmic Drug Packaging Market Overview:
    The global ophthalmic drug packaging market is expected to grow steadily, reaching an estimated value of US$527.8 million by 2034, according to Future Market Insights' recent study.
  • One of the challenges in the global ophthalmic drug packaging market is assuring compatibility between novel packaging materials and sensitive ophthalmic medicines.
  • The global ophthalmic drug packaging market size reached US$ 222.3 million in 2019.
  • Future Market Insights offers an unbiased analysis of the ophthalmic drug packaging market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

SightMD Welcomes Cynthia Zara, OD to its expert team in New York

Retrieved on: 
Monday, March 4, 2024

HAUPPAUGE, N.Y., March 4, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.
  • HAUPPAUGE, N.Y., March 4, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.
  • Cynthia Zara, OD is a board-certified optometrist providing dilation exams, contact lenses and eyeglasses, dry eye treatments, and more.
  • When asked what she is looking forward to most about joining the SightMD Team, Dr Zara said "I am excited to be joining SightMD in Hamptons Bays and Southampton.

SightMD Welcomes J. Kevin Belville, MD to its expert team

Retrieved on: 
Tuesday, February 13, 2024

HAUPPAUGE, Md., Feb. 13, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes J. Kevin Belville, MD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes J. Kevin Belville, MD to its expert team.
  • HAUPPAUGE, Md., Feb. 13, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes J. Kevin Belville, MD to its expert team.
  • Dr. J. Kevin Belville is a board-certified ophthalmologist who completed his residency as Chief Resident at Cornell Medical Center at the New York-Presbyterian Columbia University Hospital in New York City.
  • SightMD is actively seeking ophthalmology professionals who are interested in joining our outstanding team.

Ocular Therapeutix™ Announces First Subjects Screened in Phase 3 Pivotal Clinical Trial of AXPAXLI™ in Wet AMD

Retrieved on: 
Tuesday, February 13, 2024

The Company previously announced FDA agreement on its Special Protocol Assessment (SPA) Agreement Modification on January 25th.

Key Points: 
  • The Company previously announced FDA agreement on its Special Protocol Assessment (SPA) Agreement Modification on January 25th.
  • “The screening of these subjects in the pivotal Phase 3 SOL-1 trial of AXPAXLI marks an exciting milestone for Ocular Therapeutix,” said Antony Mattessich, CEO of Ocular Therapeutix.
  • We believe that AXPAXLI could set a new standard in wet AMD therapy by significantly extending time between treatments.
  • “Clinical trials like the SOL-1 study for AXPAXLI represent a critical step forward in our pursuit of more patient-centric treatments for wet AMD.

Free immersive online training available for California caregivers

Retrieved on: 
Monday, February 12, 2024

GLENDALE, Calif., Feb. 12, 2024 /PRNewswire/ -- California caregivers can see the world through the eyes of the people they care for through a free immersive online training developed by Embodied Labs, in partnership with Front Porch and the Front Porch Center for Innovation and Wellbeing (FPCIW).

Key Points: 
  • Front Porch Center for Innovation and Wellbeing partners with Embodied Labs to provide direct care workers, friends and family caregivers with cutting edge technology
    The award-winning caregiver training platform is available for paid care workers, as well as for family or friend caregivers of older adults in California.
  • FPCIW is partnering as a Center of Excellence with Embodied Labs, a CalGrows Innovation Fund Award Winner , to offer free training to direct care workers and friends/family caregivers in California.
  • "Through immersive experiences, formal and informal caregivers can embody the perspectives and conditions of other people, gaining a unique understanding not found in traditional training tools."
  • "Embodied Labs is positioned to support these heroes by providing caregiver training and tools that build empathy and understanding," says Park.

Stakes Are High for Regeneron's Eylea HD as Genentech's Vabysmo Continues to Gain Momentum, Prompting Doctors to Weigh Their Options Between Two Industry Titans, According to Spherix Global Insights

Retrieved on: 
Thursday, February 8, 2024

Wet AMD poses a particularly severe threat to vision, necessitating treatment with biologic therapies administered in four to twelve-week intervals.

Key Points: 
  • Wet AMD poses a particularly severe threat to vision, necessitating treatment with biologic therapies administered in four to twelve-week intervals.
  • However, the current treatment landscape often burdens elderly patients with high treatment frequencies, impacting their ability to attend all appointments.
  • Spherix Global Insights conducted an in-depth analysis through its RealTime Dynamix™ report series, delving into the evolving perceptions of ophthalmologists (n=101) regarding approved therapies for wet AMD.
  • In January 2024, ophthalmologists were surveyed on their preferred biologic treatment for wet AMD among other topics.